| 主权项 |
1. A method of evaluating a patient's risk of developing PML, the method comprising:
determining expression levels of one or more B cell marker in a biological sample from the patient, wherein if there is a significant difference in expression levels compared to a reference standard, the patient is determined to be at higher risk of developing PML, and wherein if the expression levels are the same or substantially similar to the reference standard, the patient is determined to be at a lower risk of developing PML. |
